<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38513611</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1750-2659</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Influenza and other respiratory viruses</Title><ISOAbbreviation>Influenza Other Respir Viruses</ISOAbbreviation></Journal><ArticleTitle>Changes in Viral Dynamics Following the Legal Relaxation of COVID-19 Mitigation Measures in Japan From Children to Adults: A Single Center Study, 2020-2023.</ArticleTitle><Pagination><StartPage>e13278</StartPage><MedlinePgn>e13278</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e13278</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/irv.13278</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Respiratory infections are an ongoing global health challenge. The COVID-19 pandemic triggered global nonpharmacological measures that reshaped public health. In Japan, the shift from legal to individual discretion in pandemic management started on May 8, 2023. However, it still unknown how the relaxation of measures affects respiratory pathogens across age groups.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We collected 16,946 samples from 13,526 patients between February 2020 and September 2023, analyzing the circulating respiratory pathogen dynamics using FilmArray respiratory panel.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our analysis revealed significant increases in the positivity rates of respiratory pathogens across multiple age groups after relaxation. The pathogens including adenovirus, Bordetella pertussis, parainfluenza 2 and parainfluenza 4 showed increased positivity predominantly in children aged under 10 years. Conversely, some pathogens including human metapneumovirus, rhinovirus/enterovirus, and respiratory virus (RSV) increased in broad range of age groups. SARS-CoV-2 positivity rates decreased in children under 10 years but increased in those aged over 60 years.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Age-stratified analysis reveals a dynamic pattern of circulating pathogen in each age group after relaxation measures. This study provides essential epidemiologic data that can guide strategies to protect different age groups and effectively respond to respiratory infections in post-COVID-19 era.</AbstractText><CopyrightInformation>© 2024 The Authors. Influenza and Other Respiratory Viruses published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hirotsu</LastName><ForeName>Yosuke</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-8002-834X</Identifier><AffiliationInfo><Affiliation>Genome Analysis Center, Yamanashi Central Hospital, Kofu, Yamanashi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagakubo</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Genome Analysis Center, Yamanashi Central Hospital, Kofu, Yamanashi, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Microbiology in Clinical Laboratory, Yamanashi Central Hospital, Kofu, Yamanashi, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Genetics and Clinical Laboratory, Yamanashi Central Hospital, Kofu, Yamanashi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maejima</LastName><ForeName>Makoto</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Microbiology in Clinical Laboratory, Yamanashi Central Hospital, Kofu, Yamanashi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shibusawa</LastName><ForeName>Masahiro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Microbiology in Clinical Laboratory, Yamanashi Central Hospital, Kofu, Yamanashi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hosaka</LastName><ForeName>Kazuhiro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Microbiology in Clinical Laboratory, Yamanashi Central Hospital, Kofu, Yamanashi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sueki</LastName><ForeName>Hitomi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Microbiology in Clinical Laboratory, Yamanashi Central Hospital, Kofu, Yamanashi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mochizuki</LastName><ForeName>Hitoshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Genome Analysis Center, Yamanashi Central Hospital, Kofu, Yamanashi, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Central Clinical Laboratory, Yamanashi Central Hospital, Kofu, Yamanashi, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Gastroenterology, Yamanashi Central Hospital, Kofu, Yamanashi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omata</LastName><ForeName>Masao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Yamanashi Central Hospital, Kofu, Yamanashi, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Grant-in-Aid for the Genome Research Project from Yamanashi Prefecture</Agency><Country /></Grant><Grant><GrantID>20H03668</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country /></Grant><Grant><GrantID>23H02955</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country /></Grant><Grant><GrantID>JP18K16292</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country /></Grant><Grant><Agency>Yasuda Memorial Medical Foundation</Agency><Country /></Grant><Grant><Agency>Uehara Memorial Foundation</Agency><Country /></Grant><Grant><Agency>Takeda Medical Research Foundation</Agency><Country /></Grant><Grant><Agency>Kato Memorial Bioscience Foundation</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Influenza Other Respir Viruses</MedlineTA><NlmUniqueID>101304007</NlmUniqueID><ISSNLinking>1750-2640</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018184" MajorTopicYN="Y">Paramyxoviridae Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID‐19</Keyword><Keyword MajorTopicYN="N">RSV</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">rhinovirus</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>22</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>21</Day><Hour>19</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38513611</ArticleId><ArticleId IdType="pmc">PMC10957242</ArticleId><ArticleId IdType="doi">10.1111/irv.13278</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lai S., Ruktanonchai N. W., Zhou L., et al., “Effect of Non‐Pharmaceutical Interventions to Contain COVID‐19 in China,” Nature 585, no. 7825 (2020): 410–413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116778</ArticleId><ArticleId IdType="pubmed">32365354</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng L., Zhang T., Wang Q., et al., “Impact of COVID‐19 Outbreaks and Interventions on Influenza in China and the United States,” Nature Communications 12, no. 1 (2021): 3249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8167168</ArticleId><ArticleId IdType="pubmed">34059675</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaxman S., Mishra S., Gandy A., et al., “Estimating the Effects of Non‐Pharmaceutical Interventions on COVID‐19 in Europe,” Nature 584, no. 7820 (2020): 257–261.</Citation><ArticleIdList><ArticleId IdType="pubmed">32512579</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh J., Lee H.‐Y., Khuong Q. L., et al., “Mobility Restrictions Were Associated With Reductions in COVID‐19 Incidence Early in the Pandemic: Evidence From a Real‐Time Evaluation in 34 Countries,” Scientific Reports 11, no. 1 (2021): 13717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8253807</ArticleId><ArticleId IdType="pubmed">34215764</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao J., Dai J., Hu J., et al., “Co‐Benefits of Nonpharmaceutical Intervention Against COVID‐19 on Infectious Diseases in China: A Large Population‐Based Observational Study,” The Lancet Regional Health – Western Pacific 17 (2021): 17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8484818</ArticleId><ArticleId IdType="pubmed">34611630</ArticleId></ArticleIdList></Reference><Reference><Citation>Angoulvant F., Ouldali N., Yang D. D., et al., “Coronavirus Disease 2019 Pandemic: Impact Caused by School Closure and National Lockdown on Pediatric Visits and Admissions for Viral and Nonviral Infections—A Time Series Analysis,” Clinical Infectious Diseases 72, no. 2 (2021): 319–322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314162</ArticleId><ArticleId IdType="pubmed">33501967</ArticleId></ArticleIdList></Reference><Reference><Citation>Redlberger‐Fritz M., Kundi M., Aberle S. W., and Puchhammer‐Stöckl E., “Significant Impact of Nationwide SARS‐CoV‐2 Lockdown Measures on the Circulation of Other Respiratory Virus Infections in Austria,” Journal of Clinical Virology 137 (2021): 104795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7962988</ArticleId><ArticleId IdType="pubmed">33761423</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirotsu Y., Maejima M., Shibusawa M., et al., “Analysis of Covid‐19 and Non‐Covid‐19 Viruses, Including Influenza Viruses, to Determine the Influence of Intensive Preventive Measures in Japan,” Journal of Clinical Virology 129 (2020): 104543.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7340051</ArticleId><ArticleId IdType="pubmed">32663787</ArticleId></ArticleIdList></Reference><Reference><Citation>The Cabinet Secretariat in Japan , “Basic Policies for Novel Coronavirus Disease Control,” 2020.</Citation></Reference><Reference><Citation>Nomura S., Yoneoka D., Tanoue Y., et al., “Time to Reconsider Diverse Ways of Working in Japan to Promote Social Distancing Measures Against the COVID‐19,” Journal of Urban Health 97, no. 4 (2020): 457–460.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow E. J., Uyeki T. M., and Chu H. Y., “The Effects of the COVID‐19 Pandemic on Community Respiratory Virus Activity,” Nature Reviews. Microbiology 21, no. 3 (2023): 195–210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9574826</ArticleId><ArticleId IdType="pubmed">36253478</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuitunen I., Artama M., Haapanen M., and Renko M., “Respiratory Virus Circulation in Children After Relaxation of COVID‐19 Restrictions in Fall 2021—A Nationwide Register Study in Finland,” Journal of Medical Virology 94, no. 9 (2022): 4528–4532.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9347728</ArticleId><ArticleId IdType="pubmed">35577532</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodjat P., Christensen P. A., Subedi S., Bernard D. W., Olsen R. J., and Long S. W., “The Reemergence of Seasonal Respiratory Viruses in Houston, Texas, After Relaxing COVID‐19 Restrictions,” Microbiology Spectrum 9, no. 2 (2021): e00430–21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8557899</ArticleId><ArticleId IdType="pubmed">34494861</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagakubo Y., Hirotsu Y., Maejima M., et al., “Non‐Pharmaceutical Interventions During the COVID‐19 Epidemic Changed Detection Rates of Other Circulating Respiratory Pathogens in Japan,” PLoS ONE 17, no. 1 (2022): e0262874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8782330</ArticleId><ArticleId IdType="pubmed">35061862</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirotsu Y., Kobayashi H., Kakizaki Y., et al., “Multidrug‐Resistant Mutations to Antiviral and Antibody Therapy in an Immunocompromised Patient Infected With SARS‐CoV‐2,” Medicina 4 (2023): 813–824.e4.</Citation><ArticleIdList><ArticleId IdType="pubmed">37683636</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirotsu Y., Kakizaki Y., Saito A., et al., “Lung Tropism in Hospitalized Patients Following Infection With SARS‐CoV‐2 Variants From D614G to Omicron BA.2,” Communication &amp; Medicine 3, no. 1 (2023): 32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9959956</ArticleId><ArticleId IdType="pubmed">36841870</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirae K., Hoshina T., and Koga H., “Impact of the COVID‐19 Pandemic on the Epidemiology of Other Communicable Diseases in Japan,” International Journal of Infectious Diseases 128 (2023): 265–271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9837205</ArticleId><ArticleId IdType="pubmed">36642212</ArticleId></ArticleIdList></Reference><Reference><Citation>Ujiie M., Tsuzuki S., Nakamoto T., and Iwamoto N., “Resurgence of Respiratory Syncytial Virus Infections During COVID‐19 Pandemic, Tokyo, Japan,” Emerging Infectious Disease Journal. 27, no. 11 (2021): 2969–2970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8544984</ArticleId><ArticleId IdType="pubmed">34388086</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohnishi T. and Kawano Y., “Resurgence of Respiratory Syncytial Virus Infection During an Atypical Season in Japan,” Journal of the Pediatric Infectious Diseases Society. 10, no. 10 (2021): 982–983.</Citation><ArticleIdList><ArticleId IdType="pubmed">34329462</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozeki S., Kawada J.‐i., Yamashita D., et al., “Impact of the Coronavirus Disease 2019 Pandemic on the Clinical Features of Pediatric Respiratory Syncytial Virus Infection in Japan,” Open Forum Infectious Diseases 9, no. 11 (2022): ofac562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9620303</ArticleId><ArticleId IdType="pubmed">36381619</ArticleId></ArticleIdList></Reference><Reference><Citation>Takashita E., Kawakami C., Momoki T., et al., “Increased Risk of Rhinovirus Infection in Children During the Coronavirus Disease‐19 Pandemic,” Influenza and Other Respiratory Viruses 15, no. 4 (2021): 488–494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189209</ArticleId><ArticleId IdType="pubmed">33715290</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberger Opek M., Yeshayahu Y., Glatman‐Freedman A., Kaufman Z., Sorek N., and Brosh‐Nissimov T., “Delayed Respiratory Syncytial Virus Epidemic in Children After Relaxation of COVID‐19 Physical Distancing Measures, Ashdod, Israel, 2021,” Eurosurveillance. 26, no. 29 (2021): 2100706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8299746</ArticleId><ArticleId IdType="pubmed">34296678</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuitunen I., Artama M., Haapanen M., and Renko M., “Record High Parainfluenza Season in Children After Relaxation of COVID‐19 Restrictions in Fall 2021—A Nationwide Register Study in Finland,” Influenza and Other Respiratory Viruses 16, no. 4 (2022): 613–616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9111305</ArticleId><ArticleId IdType="pubmed">35315214</ArticleId></ArticleIdList></Reference><Reference><Citation>Pérez‐López A., Al Mana H., Iqbal M., Suleiman M., Hasan M. R., and Tang P., “Resurgence of Influenza a Infections in Children After the Relaxation of COVID‐19‐Related Social Distancing Measures and Normalization of International Travel in Qatar,” Journal of Travel Medicine 29, no. 8 (2022): taac107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9619463</ArticleId><ArticleId IdType="pubmed">36150023</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita S., Ikegame S., Nakatomi K., et al., “Respiratory Virus Infections During the COVID‐19 Pandemic Revealed by Multiplex PCR Testing in Japan,” Microbiology Spectrum 11, no. 2 (2023): e04162–22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10100992</ArticleId><ArticleId IdType="pubmed">36723071</ArticleId></ArticleIdList></Reference><Reference><Citation>Amar S., Avni Y. S., O'Rourke N., and Michael T., “Prevalence of Common Infectious Diseases After COVID‐19 Vaccination and Easing of Pandemic Restrictions in Israel,” JAMA Network Open 5, no. 2 (2022): e2146175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8808334</ArticleId><ArticleId IdType="pubmed">35103792</ArticleId></ArticleIdList></Reference><Reference><Citation>Bavel J. J. V., Baicker K., Boggio P. S., et al., “Using Social and Behavioural Science to Support COVID‐19 Pandemic Response,” Nature Human Behaviour 4, no. 5 (2020): 460–471.</Citation><ArticleIdList><ArticleId IdType="pubmed">32355299</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper C. A., Satchell L. P., Fido D., and Latzman R. D., “Functional Fear Predicts Public Health Compliance in the COVID‐19 Pandemic,” International Journal of Mental Health and Addiction 19, no. 5 (2021): 1875–1888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7185265</ArticleId><ArticleId IdType="pubmed">32346359</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami K., Kuriyama S., and Hashimoto H., “General Health Literacy, COVID‐19‐Related Health Literacy, and Protective Behaviors: Evidence From a Population‐Based Study in Japan,” Frontiers in Public Health 11 (2023): 11, 10.3389/fpubh.2023.1208815</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1208815</ArticleId><ArticleId IdType="pmc">PMC10547581</ArticleId><ArticleId IdType="pubmed">37794892</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko Y. K., Kinoshita R., Yamauchi M., et al., “Impact of the Coming‐of‐Age Day and Ceremony on the Risk of SARS‐CoV‐2 Transmission in Japan: A Natural‐Experimental Study Based on National Surveillance Data,” Influenza and Other Respiratory Viruses 16, no. 6 (2022): 1026–1032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9353391</ArticleId><ArticleId IdType="pubmed">35894771</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>